Clal Biotechnology Industries Ltd

XTAE:CBI (Israel)  
₪ 0.45 (+7.16%) Apr 17
At Loss
P/B:
0.67
Market Cap:
₪ 70.42M ($ 18.56M)
Enterprise V:
₪ 92.83M ($ 24.47M)
Volume:
338.28K
Avg Vol (2M):
133.63K
Also Trade In:
Volume:
338.28K
At Loss
Market Cap ₪ M 70.42
Enterprise Value ₪ M 92.83
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book 0.67
Price/Sales 213.00
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) ₪ M --
EPS (TTM) ₪ -0.18
Beneish M-Score -2.91
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % --
y-y EBITDA Growth Rate % 30.60
EV-to-EBIT 1.46
EV-to-EBITDA 1.35
PEG --
Shares Outstanding M 156.85
Net Margin (%) -9,651.56
Operating Margin % -2,367.47
Pre-tax Margin (%) 21,900.00
Quick Ratio 2.21
Current Ratio 2.21
ROA % (ttm) -15.61
ROE % (ttm) -23.27
ROIC % (ttm) -4.10
Dividend Yield % --
Altman Z-Score -9.31
Piotroski F-Score 5.00
Positive ROA N
Positive CFROA N
Higher ROA y-y Y
Cash flow > Earnings Y
Lower Leverage y-y N
Higher Current Ratio y-y Y
Less Shares Outstanding y-y Y
Gross Margin Increase y-y Y
Higher Asset Turnover y-y N

XTAE:CBI Number of Guru Trades

To

XTAE:CBI Volume of Guru Trades

To

Gurus Latest Trades with XTAE:CBI

No Available Data

XTAE:CBI is held by these investors

No Available Data